|Ms. Ting Zheng||Chairperson , CEO & CEO of Beijing Division||1.03M||N/A||1972|
|Mr. Bing Chuen Chen||CFO & Director||976.87k||N/A||1976|
|Ms. Xin Xu||Chief Technology Officer||131.39k||N/A||1954|
|Ms. Rui Arashiyama||Chief Exec. Officer of Guangdong & Zhejiang Divisions||258.28k||N/A||1959|
|Ms. Cathy Bai||VP of Corp. Fin.||N/A||N/A||N/A|
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2020, it had three operating cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).
Global Cord Blood Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.